In this study, reference values for routine liver function tests and hematological parameters are established, which are frequently done to detect and monitor liver injury and assess hematological status of subjects. It is to be noted that the established reference values will greatly help monitor patients who would receive antiretroviral therapy (ART. The adverse events following ART include liver damage. It will also provide background information for the clinical trials that might be conducted in the country, including those planned in the immediate future at the Armauer Hansen Research Institute (AHRI).
